MedPath

Shanghai Renji Hospital,Shanghai Jiaotong University,School of Medicine

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Nasal Mask Kit in Gastrointestinal Endoscopy

Not Applicable
Recruiting
Conditions
Gastric Polyp
Colon Polyp
Hypoxia
Gastric Cancer
Colon Cancer
Esophageal Cancer
Interventions
Device: nasal mask oxygen kit
Device: regular nasal cannula
First Posted Date
2022-06-06
Last Posted Date
2022-09-08
Lead Sponsor
RenJi Hospital
Target Recruit Count
1200
Registration Number
NCT05405530
Locations
🇨🇳

Henan Provincial People's Hospital, Zhengzhou, Henan, China

🇨🇳

First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China

🇨🇳

Renji Hospital, Shanghai, Shanghai, China

Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery

Not Applicable
Recruiting
Conditions
Digestive System Disease
Gynecological Disease
Urologic Diseases
Orthopedic Surgery
Interventions
First Posted Date
2022-06-02
Last Posted Date
2023-01-23
Lead Sponsor
RenJi Hospital
Target Recruit Count
2968
Registration Number
NCT05401058
Locations
🇨🇳

The first Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

🇨🇳

Henan Provincial People Hospital, Zhengzhou, Henan, China

🇨🇳

Renji Hospital, Shanghai Jiaotong University School of Medicine, Pudong, Shanghai, China

and more 3 locations

Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer

Phase 2
Recruiting
Conditions
Urothelial Carcinoma Bladder
PD-1 Inhibitor
Interventions
First Posted Date
2022-06-02
Last Posted Date
2022-08-18
Lead Sponsor
RenJi Hospital
Target Recruit Count
20
Registration Number
NCT05401279
Locations
🇨🇳

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China

Epidemiological Study on Malignancy Complicated With Renal Injury

Not yet recruiting
Conditions
Kidney Injury
First Posted Date
2022-05-26
Last Posted Date
2022-05-26
Lead Sponsor
RenJi Hospital
Target Recruit Count
30000
Registration Number
NCT05392725

Faster Peritoneal Solute Transfer Rate and Survival in a Pre-APD and Icodextrin Peritoneal Dialysis Cohort

Completed
Conditions
Peritoneal Dialysis
First Posted Date
2022-05-19
Last Posted Date
2022-05-19
Lead Sponsor
RenJi Hospital
Target Recruit Count
430
Registration Number
NCT05381051

Echocardiographic Manifestation in Patients With Omicron Variant of COVID-19

Conditions
COVID-19
Interventions
Other: Echocardiography
First Posted Date
2022-05-18
Last Posted Date
2022-05-18
Lead Sponsor
RenJi Hospital
Target Recruit Count
200
Registration Number
NCT05379543
Locations
🇨🇳

Renji Hospital, Shanghai, China

The Safety of Paxlovid in Hemodialysis Patients With Covid-19

First Posted Date
2022-05-09
Last Posted Date
2022-06-14
Lead Sponsor
RenJi Hospital
Target Recruit Count
18
Registration Number
NCT05366192
Locations
🇨🇳

Department of Nephrology, Renji Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, Shanghai, China

Functional Prognosis of Post-operative Patients With Cerebral Small Vascular Disease(CSVD)

Conditions
Long Term Adverse Effects
Cerebral Small Vessel Diseases
First Posted Date
2022-05-04
Last Posted Date
2022-05-04
Lead Sponsor
RenJi Hospital
Target Recruit Count
212
Registration Number
NCT05359588
Locations
🇨🇳

Renji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, Shanghai, China

CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial

Not Applicable
Recruiting
Conditions
Circulating Tumor Cell
Breast Cancer
Interventions
Device: GILUPI CellCollector®
First Posted Date
2022-05-04
Last Posted Date
2023-11-21
Lead Sponsor
RenJi Hospital
Target Recruit Count
484
Registration Number
NCT05360290
Locations
🇨🇳

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China

A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.

Phase 2
Conditions
Unresectable Locally Advanced Pancreatic Cancer
First Posted Date
2022-04-26
Last Posted Date
2022-04-26
Lead Sponsor
RenJi Hospital
Target Recruit Count
20
Registration Number
NCT05346146
Locations
🇨🇳

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath